Ms González Hernández, how is Nobel Biocare participating in EuroPerio11, and what can attendees look forward to at your booth?
EuroPerio represents a premier opportunity to connect with dental professionals dedicated to periodontics and implantology. It provides an ideal setting in which to present our expanding portfolio, which focuses on supporting soft-tissue preservation and enhancing biological integration around implants.

At our booth this year, we are highlighting our enhanced solutions designed to respect biological principles, maintain soft-tissue integrity and promote soft-tissue integration after implant procedures. Featured elements include a new emergence profile for our recently launched multi-unit abutments, our core abutment concept and the Xeal surface—all supported by robust clinical data.

A product becomes a true solution when seamlessly integrated into a digital workflow. We are therefore pleased to present our comprehensive end-to-end digital offering for aesthetic full-arch treatments. This includes diagnostic and treatment planning capabilities powered by the new artificial intelligence-driven DTX Studio Clinic, flexible surgical execution—whether free-hand, guided or navigated via X-Guide—and efficient provisionalisation through photogrammetry and high-precision 3D printing using SprintRay technology. These advancements are designed to increase precision, predictability and efficiency in everyday clinical practice, ultimately improving patient outcomes.

We will also be showcasing our comprehensive regenerative portfolio, designed to support clinicians across a range of indications and reconstruction requirements. Our goal is to offer a broad and effective set of regenerative tools for the preservation, regeneration and rehabilitation of both soft and hard tissue.

Could you tell us more about the corporate forum you’re hosting at EuroPerio11?
We are particularly enthusiastic about this year’s corporate forum on 16 May. For this session, we have collaborated with leading experts in soft- and hard-tissue management: Drs Istvan Urban, Luca De Stavola and Giacomo Fabbri.

During their 90-minute presentation, they will explore advanced approaches to implant therapy, including a novel technique for augmentation of the inter-implant papillae, as well as discuss the influence of abutment surface properties on soft-tissue integration and the impact of implant positioning on long-term peri-implant tissue health. Participants will not only have the opportunity to engage with these internationally recognised clinicians, but will also gain valuable insights into surgical innovation, the latest biomaterials, and biomechanical strategies for optimising both aesthetic and biological results.

Regenerative products seem to be an important part of your portfolio. What are some of the latest developments on that front?
Regenerative therapies are often key to the long-term success of implant treatments. Since acquiring Osteogenics, we’ve significantly expanded our portfolio in this area. This includes an extended range of PTFE membranes—some of which are titanium-reinforced—as well as the Urban membrane, designed for advanced augmentation. Additionally, we provide a selection of dedicated suture materials and fixation pins and screws to ensure optimal membrane stabilisation.

Throughout the three-day event, visitors have the opportunity to explore our regenerative solutions in detail at our booth. It is an excellent occasion to develop a deeper understanding of our offerings and how they support clinicians in diverse clinical scenarios.